Recent Updates
Recently added Catalysts
AMGN

Amgen to Present at the Leerink Swann Global Healthcare Conference Amgen (NASDAQ:AMGN) will present at the Leerink Swann Global Healthcare Conference at 9:30 a.m. Eastern Standard Time on Thursday, Feb. 16, 2012, at...

Key Takeaway: THOUSAND OAKS, Calif. , Feb. 13, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the Leerink Swann Global Healthcare Conference at 9:30 a.m. Eastern Standard Time on Thursday, Feb. 16, 2012 , at the Waldorf Astoria Hotel in New York City. Jonathan M. Peacock , executiv

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif. , Feb. 13, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the Leerink Swann Global Healthcare Conference at 9:30 a.m. Eastern Standard Time on Thursday, Feb. 16, 2012 , at the Waldorf Astoria Hotel in New York City. Jonathan M. Peacock , executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Arvind Sood , 805-447-1060 (investors)
Last updated: Feb 13, 2012